Thus, our present and previous results suggest that hyperandrogenemia may contribute to the reduced clinical pregnancy rate following embryo transfer as part of in vitro fertilization programs in women with PCOS by modulating expressions of AR and HOXA10. The gene discussed is HOXA10; the disease is polycystic ovary syndrome.